![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Shaoxing Jingxin Pharmaceutical Co., Ltd. Shangyu Cn, based in China, is a pharmaceutical company that stands out with its certifications from EDQM.
One of their significant offerings is Simvastatin, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2005-300 - Rev 06
This Chemical and TSE Type CEP, issued on January 26, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1563 associated with this CEP further emphasizes